[Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].
D001855:Bone Marrow Diseases / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002927:Cimetidine / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004363:Drug Utilization; D005069:Evaluation Studies as Topic; D006801:Humans; D007154:Immune System Diseases / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing
D002927:Cimetidine
Farmaco-vigilanza. Monitoraggio degli effetti collaterali dei farmaci in fase post-marketing: la cimetidina. Parte II.